Transcription of 慢性B型肝炎治療的今日觀 - tma.tw
{{id}} {{{paragraph}}}
B 2009 EASL B hepatitis B virus, HBV B HBV 1,2 2007 2009 American Association for the Study of Liver Diseases, AASLD European Association for the Study o f t h e L i v e r, E A S L ( A s i a n Pacific Association for the Study of the Liver, APASL 2 0 0 9 4 22-26 Bella Center 44 EASL B clinical practice guideline B B B B 5 cumulative incidence 8-20% 5 20% 5 80-86% 5 14-35% B 2-5%)
學 術 表3 目前臨床上常用的各種不同抗病毒藥物優缺點之比較(1,3) 表4 b型肝炎口服核苷類藥物治療目標點之準則(3-6) 抗病毒藥物 優點 缺點
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}